Niceville, Florida, United States The venture was found in North America in United States. The main office of represented VC is situated in the Niceville.
The typical case for the fund is to invest in rounds with 1 participant. Despite the 10X Fund LP, startups are often financed by National Institutes of Health. In the next rounds fund is usually obtained by National Institutes of Health.
This organization was formed by James Czirr, Rod D. Martin.
The real fund results show that this VC is 10 percentage points less often commits exit comparing to other companies. The top amount of exits for fund were in 2012. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2009. Comparing to the other companies, this 10X Fund LP performs on 19 percentage points less the average number of lead investments. The common things for fund are deals in the range of 100 thousands - 1 million dollars.
Among the various public portfolio startups of the fund, we may underline Galectin Therapeutics Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Pharmaceutical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Related Funds
Funds with similar focus
| Fund Name | Location |
| BeyondTrust | California, Carlsbad, United States |
| Centripetal Capital Partners | Connecticut, Stamford, United States |
| Essel Group ME | Dubai, United Arab Emirates |
| FBR & Co | Arlington, United States, Virginia |
| Glory Capital | Beijing, Beijing, China |
| GoldTech | Beijing, Beijing, China |
| Huahang Investment | China, Japan, Kagoshima Prefecture |
| Navam Capital | Calcutta Bagh Bazar, India, West Bengal |
| NuState Capital | - |
| Rock River Capital Partners | Madison, United States, Wisconsin |
| Shenzhen Gaea Technology Corp. | Beijing, Beijing, China |
| Siemens | Bayern, Germany, Munich |
| The Husseini Group | Beverly Hills, California, United States |
| Vela Technologies | England, London, United Kingdom |
| wolf biotech gmbh | Bayern, Germany, Starnberg |
| Wumart | Beijing, Beijing, China |
| Youngtree Partners | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Galectin Therapeutics | $570K | 10 May 2010 | Georgia, United States | ||
Galectin Therapeutics | $310K | 04 May 2010 | Georgia, United States | ||
Galectin Therapeutics | $335K | 08 Mar 2010 | Georgia, United States | ||
Galectin Therapeutics | $325K | 02 Feb 2010 | Georgia, United States | ||
Galectin Therapeutics | $325K | 10 Dec 2009 | Georgia, United States | ||
Galectin Therapeutics | $310K | 04 Nov 2009 | Georgia, United States | ||
Galectin Therapeutics | $325K | 06 Oct 2009 | Georgia, United States | ||
Galectin Therapeutics | $500K | 30 Jun 2009 | Georgia, United States | ||
Galectin Therapeutics | $900K | 13 May 2009 | Georgia, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Galectin Therapeutics | $570K | 10 May 2010 | Georgia, United States | ||
Galectin Therapeutics | $310K | 04 May 2010 | Georgia, United States | ||
Galectin Therapeutics | $335K | 08 Mar 2010 | Georgia, United States | ||
Galectin Therapeutics | $325K | 02 Feb 2010 | Georgia, United States | ||
Galectin Therapeutics | $325K | 10 Dec 2009 | Georgia, United States | ||
Galectin Therapeutics | $310K | 04 Nov 2009 | Georgia, United States | ||
Galectin Therapeutics | $325K | 06 Oct 2009 | Georgia, United States | ||
Galectin Therapeutics | $500K | 30 Jun 2009 | Georgia, United States | ||
Galectin Therapeutics | $900K | 13 May 2009 | Georgia, United States |
